Mucorales Infection

1

Review clinical trials related to Mucorales Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Biomarkers for Invasive Mucormycosis

Mucormycosis (MM) is one of the main invasive fungal infection (IFI), and is determined by filamentous fungi belonging to the order of Mucorales, with a mortality rate ranging from 20 to 60% according to localization. Prompt initiation of adequate antifungal therapy is critical for treating mucormycosis. Early diagnostic is therefore essential. The presence in the Mucorales' cell wall of uncommon monosaccharides open interesting perspectives for the development of specific diagnostic biomarkers. This study evaluate a diagnostic test for mucormycosis in a cohort of patients with MM and in control groups (high-risk patients without MM and patients with another IFI).

Participants needed: 100
Trial details
Age: 3-64Biological sex: AllType: ObservationalSponsor: University Hospital, LilleUpdated: May 22, 2026Locations: 1
Eligibility criteria

Men and women [+8]

Patients for whom the inclusion criteria are not met [+1]